These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2573817)

  • 1. [Amplification and expression of oncogenes in human malignant tumors--organ or tissue specificity and prognosis].
    Ueda M; Shimizu N; Abe O
    Nihon Geka Gakkai Zasshi; 1989 Sep; 90(9):1579-81. PubMed ID: 2573817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amplification and rearrangement of c-erb B proto-oncogenes in cancer of human female genital tract.
    Zhang X; Silva E; Gershenson D; Hung MC
    Oncogene; 1989 Aug; 4(8):985-9. PubMed ID: 2569708
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification of c-myc and c-erbB-2 proto-oncogenes in human solid tumors: frequency and clinical significance.
    Gutman M; Ravia Y; Assaf D; Yamamoto T; Rozin R; Shiloh Y
    Int J Cancer; 1989 Nov; 44(5):802-5. PubMed ID: 2573579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Proto-oncogene C-erbB-2 and human cancer].
    Toyoshima K
    Gan To Kagaku Ryoho; 1990 Mar; 17(3 Pt 1):309-14. PubMed ID: 1968737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations in copy number of c-erbB-2 and c-myc proto-oncogenes in advanced stage of human breast cancer.
    Tsuda H; Hirohashi S; Hirota T; Shimosato Y
    Acta Pathol Jpn; 1991 Jan; 41(1):19-23. PubMed ID: 1674395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amplification and overexpression of the erbB-2 gene in human tumors: its involvement in tumor development, significance as a prognostic factor, and potential as a target for cancer therapy.
    Hynes NE
    Semin Cancer Biol; 1993 Feb; 4(1):19-26. PubMed ID: 8095411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C-myc, N-myc, N-ras, and c-erb-B: lack of amplification or rearrangement in human medullary thyroid carcinoma and a derivative cell line.
    Yang KP; Castillo SG; Nguyen CV; Hickey RC; Samaan NA
    Anticancer Res; 1990; 10(1):189-92. PubMed ID: 2185686
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic alterations in c-erbB-2 protooncogene as prognostic markers in human primary breast tumors.
    Nagai MA; Marques LA; Torloni H; Brentani MM
    Oncology; 1993; 50(6):412-7. PubMed ID: 7901824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amplification of cellular oncogenes: a predictor of clinical outcome in human cancer.
    Schwab M; Amler LC
    Genes Chromosomes Cancer; 1990 Jan; 1(3):181-93. PubMed ID: 1982063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amplification of the proto-oncogenes int-2, c-erb B-2 and c-myc in human breast cancer.
    Machotka SV; Garrett CT; Schwartz AM; Callahan R
    Clin Chim Acta; 1989 Oct; 184(3):207-17. PubMed ID: 2611995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-erb B-2 amplification in cystic renal disease.
    Herrera GA
    Kidney Int; 1991 Sep; 40(3):509-13. PubMed ID: 1686289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of c-erb B-2/neu proto-oncogene in human prostatic cancer tissues and cell lines.
    Zhau HE; Wan DS; Zhou J; Miller GJ; von Eschenbach AC
    Mol Carcinog; 1992; 5(4):320-7. PubMed ID: 1353965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cathepsin-D and c-erb-B 2 have an additive prognostic value for breast cancer patients.
    Scorilas A; Yotis J; Gouriotis D; Keramopoulos A; Ampela K; Trangas T; Talieri M
    Anticancer Res; 1993; 13(5C):1895-900. PubMed ID: 7903524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification of ERBB-2 (HER-2/NEU) oncogene in different neoplasms of patients from USSR.
    Knyazev PG; Imyanitov EN; Chernitca OI; Nikiforova IF; Hanson KP
    Oncology; 1992; 49(2):162-5. PubMed ID: 1349430
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of either c-myc or c-erbB-2/neu proto-oncogenes in human breast carcinomas: correlation with poor prognosis.
    Guérin M; Barrois M; Terrier MJ; Spielmann M; Riou G
    Oncogene Res; 1988; 3(1):21-31. PubMed ID: 2905033
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amplification of the epidermal growth factor receptor gene in biopsy specimens from human intracranial tumours.
    Helseth E; Unsgaard G; Dalen A; Fure H; Skandsen T; Odegaard A; Vik R
    Br J Neurosurg; 1988; 2(2):217-25. PubMed ID: 2908290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
    Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
    Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proto-oncogene amplification and human breast tumor phenotype.
    Adnane J; Gaudray P; Simon MP; Simony-Lafontaine J; Jeanteur P; Theillet C
    Oncogene; 1989 Nov; 4(11):1389-95. PubMed ID: 2554239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Amplification of the erbb-2 (Her-2/NEU), erbb-1 (HER-1) and c-myc oncogenes is often combined with the deletion of the short arm of chromosome 17 in human carcinoma].
    Imianitov EN; Chernitsa OI; Nikiforova IF; Serova OM; Sokolov SI; Laur OIu; Togo AV; Kniazev PG
    Mol Biol (Mosk); 1993; 27(4):888-94. PubMed ID: 8103188
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
    Gaffey MJ; Frierson HF; Williams ME
    Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.